Access to high-cost medicines in New Zealand

Louise Curley, Maree Jensen, Zaheer-Ud-Din Babar, Sanya Ram

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.
LanguageEnglish
Title of host publication Equitable Access to High-Cost Pharmaceuticals
EditorsZaheer-Ud-Din Babar
PublisherElsevier
Chapter12
Pages183-197
Edition1st
ISBN (Electronic)9780128119624
ISBN (Print)9780128119457
Publication statusPublished - 21 Feb 2018

Fingerprint

Medicine
Costs
Pharmaceutical Preparations

Cite this

Curley, L., Jensen, M., Babar, Z-U-D., & Ram, S. (2018). Access to high-cost medicines in New Zealand. In Z-U-D. Babar (Ed.), Equitable Access to High-Cost Pharmaceuticals (1st ed., pp. 183-197). Elsevier.
Curley, Louise ; Jensen, Maree ; Babar, Zaheer-Ud-Din ; Ram, Sanya. / Access to high-cost medicines in New Zealand. Equitable Access to High-Cost Pharmaceuticals. editor / Zaheer-Ud-Din Babar. 1st . ed. Elsevier, 2018. pp. 183-197
@inbook{6dee633bbbd841d1a55769a6a7ad51fe,
title = "Access to high-cost medicines in New Zealand",
abstract = "This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.",
author = "Louise Curley and Maree Jensen and Zaheer-Ud-Din Babar and Sanya Ram",
year = "2018",
month = "2",
day = "21",
language = "English",
isbn = "9780128119457",
pages = "183--197",
editor = "Zaheer-Ud-Din Babar",
booktitle = "Equitable Access to High-Cost Pharmaceuticals",
publisher = "Elsevier",
edition = "1st",

}

Curley, L, Jensen, M, Babar, Z-U-D & Ram, S 2018, Access to high-cost medicines in New Zealand. in Z-U-D Babar (ed.), Equitable Access to High-Cost Pharmaceuticals. 1st edn, Elsevier, pp. 183-197.

Access to high-cost medicines in New Zealand. / Curley, Louise; Jensen, Maree; Babar, Zaheer-Ud-Din; Ram, Sanya.

Equitable Access to High-Cost Pharmaceuticals. ed. / Zaheer-Ud-Din Babar. 1st . ed. Elsevier, 2018. p. 183-197.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Access to high-cost medicines in New Zealand

AU - Curley,Louise

AU - Jensen,Maree

AU - Babar,Zaheer-Ud-Din

AU - Ram,Sanya

PY - 2018/2/21

Y1 - 2018/2/21

N2 - This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.

AB - This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.

UR - https://www.elsevier.com/books/equitable-access-to-high-cost-pharmaceuticals/babar/978-0-12-811945-7

M3 - Chapter

SN - 9780128119457

SP - 183

EP - 197

BT - Equitable Access to High-Cost Pharmaceuticals

PB - Elsevier

ER -

Curley L, Jensen M, Babar Z-U-D, Ram S. Access to high-cost medicines in New Zealand. In Babar Z-U-D, editor, Equitable Access to High-Cost Pharmaceuticals. 1st ed. Elsevier. 2018. p. 183-197